92 related articles for article (PubMed ID: 9758219)
1. Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig.
Campbell EA; Gentry CT; Patel S; Panesar MS; Walpole CS; Urban L
Neuroscience; 1998 Dec; 87(3):527-32. PubMed ID: 9758219
[TBL] [Abstract][Full Text] [Related]
2. Oral anti-hyperalgesic and anti-inflammatory activity of NK(1) receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig.
Campbell EA; Gentry C; Patel S; Kidd B; Cruwys S; Fox AJ; Urban L
Pain; 2000 Sep; 87(3):253-263. PubMed ID: 10963905
[TBL] [Abstract][Full Text] [Related]
3. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
4. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
Yashpal K; Hui-Chan CW; Henry JL
Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
[TBL] [Abstract][Full Text] [Related]
5. 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.
Walpole C; Ko SY; Brown M; Beattie D; Campbell E; Dickenson F; Ewan S; Hughes GA; Lemaire M; Lerpiniere J; Patel S; Urban L
J Med Chem; 1998 Aug; 41(17):3159-73. PubMed ID: 9703462
[TBL] [Abstract][Full Text] [Related]
6. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
7. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain.
Pitcher GM; Henry JL
Exp Neurol; 2004 Apr; 186(2):173-97. PubMed ID: 15026255
[TBL] [Abstract][Full Text] [Related]
8. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
Davis-Taber R; Baker S; Lehto SG; Zhong C; Surowy CS; Faltynek CR; Scott VE; Honore P
J Pain; 2008 May; 9(5):449-56. PubMed ID: 18337184
[TBL] [Abstract][Full Text] [Related]
9. Central and peripheral anti-hyperalgesic effects of diosmin in a neuropathic pain model in rats.
Carballo-Villalobos AI; González-Trujano ME; Pellicer F; Alvarado-Vásquez N; López-Muñoz FJ
Biomed Pharmacother; 2018 Jan; 97():310-320. PubMed ID: 29091880
[TBL] [Abstract][Full Text] [Related]
10. Wind-up of spinal cord neurones and pain sensation: much ado about something?
Herrero JF; Laird JM; López-García JA
Prog Neurobiol; 2000 Jun; 61(2):169-203. PubMed ID: 10704997
[TBL] [Abstract][Full Text] [Related]
11. Involvement of tachykinin NK1 receptors in nociceptin-induced hyperalgesia in mice.
Sakurada C; Sakurada S; Katsuyama S; Sasaki J; Tan-No K; Sakurada T
Brain Res; 1999 Sep; 841(1-2):85-92. PubMed ID: 10546991
[TBL] [Abstract][Full Text] [Related]
12. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat.
Gaudreau GA; Plourde V
Neurosci Lett; 2003 Nov; 351(2):59-62. PubMed ID: 14583381
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids.
Hua XY; Chen P; Marsala M; Yaksh TL
Neuroscience; 1999 Mar; 89(2):525-34. PubMed ID: 10077333
[TBL] [Abstract][Full Text] [Related]
14. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.
Teodoro FC; Tronco Júnior MF; Zampronio AR; Martini AC; Rae GA; Chichorro JG
Neuropeptides; 2013 Jun; 47(3):199-206. PubMed ID: 23177733
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
[TBL] [Abstract][Full Text] [Related]
16. The effects of SDZ NKT 343, a potent NK1 receptor antagonist, on cutaneous responses of primate spinothalamic tract neurones sensitized by intradermal capsaicin injection.
Rees H; Sluka KA; Urban L; Walpole CJ; Willis WD
Exp Brain Res; 1998 Aug; 121(3):355-8. PubMed ID: 9746141
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
18. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord.
Chapman V; Dickenson AH
Neurosci Lett; 1993 Jul; 157(2):149-52. PubMed ID: 8233046
[TBL] [Abstract][Full Text] [Related]
19. (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice.
Jiang J; Shen YY; Li J; Lin YH; Luo CX; Zhu DY
Eur J Pharmacol; 2015 Jun; 757():53-8. PubMed ID: 25835611
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist.
Cahill CM; Coderre TJ
Pain; 2002 Feb; 95(3):277-285. PubMed ID: 11839427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
